The Utility of Cannabidiol in the Treatment of Refractory Epilepsy

Posted by Joe Pavlik on

Published: Clin Pharmacol Ther. 2016 Aug 10. doi: 10.1002/cpt.441.

The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.

Reddy DS Abstract

Cannabis-derived cannabinoids such as cannabidiol (CBD) have anticonvulsant properties. Recently, there has been an emerging interest in the use of CBD-enriched products for treatment of drug-resistant epilepsy. Some pilot trials of CBD have proved beneficial for refractory epilepsy, but its efficacy is yet to be confirmed by standard placebo-controlled trials. However, the mechanisms underlying the seizure protection efficacy claims of CBD remain unclear. This review briefly describes the clinical utility of CBD in the treatment of refractory epilepsy.


Share this post



← Older Post Newer Post →


Leave a comment

Please note, comments must be approved before they are published.